Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOSHUA G COHEN

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology

NPI
1467605766
CMS profile
1145359
Location
IRVINE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$190.42

6 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $190.42 6

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
Intuitive Surgical, Inc. $86.94 3
Medtronic, Inc. $85.48 2
Memic Innovative Surgery Inc. $18.00 1

Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOSHUA G COHEN

NPI 1467605766 · CMS profile ID 1145359

Allopathic & Osteopathic Physicians / Obstetrics & Gynecology / Gynecologic Oncology

IRVINE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1467605766?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOSHUA G COHEN, NPI 1467605766, CMS profile ID 1145359. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1467605766?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). JOSHUA G COHEN, NPI 1467605766, CMS profile ID 1145359. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1467605766?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
JOSHUA G COHEN, NPI 1467605766, CMS profile ID 1145359, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1467605766?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

6 matching records · $190.42 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 6 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–6 of 6.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Memic Innovative Surgery Inc. $18.0011/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947565893 CMS
Intuitive Surgical, Inc. $28.9810/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 960581451 CMS
Medtronic, Inc. $17.7906/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930736369 CMS
Medtronic, Inc. $67.6906/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930736371 CMS
Intuitive Surgical, Inc. $28.9802/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 960674679 CMS
Intuitive Surgical, Inc. $28.9802/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 960674335 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $373.89 10
PY2020 $59.25 1
PY2021 $126.85 2
PY2022 $190.42 6
PY2023 $7,678.38 10
PY2024 $683.27 14
PY2025 $1,946.70 13

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $97,002.41 9
PY2024 Principal investigator $31,617.27 3
PY2023 Principal investigator $35,585.14 3
PY2022 Principal investigator $62,256.47 35
PY2021 Principal investigator $27,593.17 25
PY2020 Principal investigator $69,729.00 8
PY2019 Principal investigator $60,517.00 12

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

25 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $749.29 12/31/2021 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
\";A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with a germline BRCA mutation and Stage III-IV Ovarian Cancer who are in Complete or Partial Response Following First Line Platinum Based Chemotherapy\"; No dispute reported 06/30/2026 826461327
Principal investigator 1 Incyte Corporation $13.01 10/05/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831071093
Principal investigator 1 Genentech, Inc. $4,205.00 09/13/2021 Covered Recipient Teaching Hospital
UC DAVIS MEDICAL CENTER
A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM No dispute reported 06/30/2026 835928877
Principal investigator 1 Seagen Inc. $1,032.63 08/18/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
A Single Arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer No dispute reported 06/30/2026 792658273
Principal investigator 1 Genentech, Inc. $4,991.00 05/10/2021 Covered Recipient Teaching Hospital
UC DAVIS MEDICAL CENTER
A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM No dispute reported 06/30/2026 835928871
Principal investigator 1 Incyte Corporation $11.76 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070909
Principal investigator 1 Incyte Corporation $17.80 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070915
Principal investigator 1 Incyte Corporation $78.50 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070921
Principal investigator 1 Incyte Corporation $85.25 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070927
Principal investigator 1 Incyte Corporation $20.30 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070933
Principal investigator 1 Incyte Corporation $68.50 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070939
Principal investigator 1 Incyte Corporation $30.00 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070945
Principal investigator 1 Incyte Corporation $79.00 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070951
Principal investigator 1 Incyte Corporation $2.10 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070957
Principal investigator 1 Incyte Corporation $11.76 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070963
Principal investigator 1 Incyte Corporation $11.76 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070969
Principal investigator 1 Incyte Corporation $11.76 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070973
Principal investigator 1 Incyte Corporation $11.76 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070979
Principal investigator 1 Incyte Corporation $11.76 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070985
Principal investigator 1 Incyte Corporation $11.76 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070991
Principal investigator 1 Incyte Corporation $11.76 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831070999
Principal investigator 1 Incyte Corporation $17.80 05/03/2021 Covered Recipient Teaching Hospital
Resnick Neuropsychiatric Hospital At
An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204) No dispute reported 06/30/2026 831071003
Principal investigator 1 Genentech, Inc. $2,000.00 03/10/2021 Covered Recipient Teaching Hospital
UC DAVIS MEDICAL CENTER
A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM No dispute reported 06/30/2026 835928865
Principal investigator 2 AstraZeneca Pharmaceuticals LP $13,108.91 02/24/2021 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
\";A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with a germline BRCA mutation and Stage III-IV Ovarian Cancer who are in Complete or Partial Response Following First Line Platinum Based Chemotherapy\"; No dispute reported 06/30/2026 826449411
Principal investigator 1 Genentech, Inc. $1,000.00 01/27/2021 Covered Recipient Teaching Hospital
UC DAVIS MEDICAL CENTER
A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM No dispute reported 06/30/2026 835928859